-
Sixth Annual Wear White Luncheon Raises Support and Awareness for Cancer Immunotherapy
In June, the Cancer Research Institute (CRI) held its sixth annual Wear White Luncheon at the historic… -
Why We Give: Real Stories of Hope, Loss, and the Drive to a Future #Immune2Cancer
What drives someone to fund cancer research? At the Cancer Research Institute (CRI), the answers are as… -
2025 Cancer Immunotherapy Insights + Impact Report
A Decade of Progress. A Future of Possibility. The Cancer Research Institute (CRI)’s 2025 Cancer Immunotherapy Insights… -
2025 AACR-CRI Lloyd J. Old Award: Dr. Crystal Mackall Honored for Fearlessly Confronting the “Beast” of Cancer
The Cancer Research Institute (CRI) and the American Association for Cancer Research (AACR) have awarded Dr. Crystal… -
Immunotherapy vs. Chemotherapy: What’s the Difference?
We answer common questions patients ask about how immunotherapy compares to chemotherapy, including side effects and length…
-
Colorectal Cancer Rates Are Skyrocketing in Young Adults—Is Your Lifestyle Putting You at Risk?
In the United States, colorectal cancer (CRC) is the third most diagnosed cancer and the third leading… -
The Impact of Immune Monitoring for the Early Detection of Cancer
Cancer prevention and early detection are crucial in our fight against this devastating disease. While the thought… -
Early Detection Saves Lives: The Essential Cancer Screenings You Can’t Afford to Skip
Early detection and screening are some of the most powerful tools we have to help prevent cancer…. -
Celebrating Excellence: Advancing Inclusion in Cancer Immunology
This Black History Month, we proudly honor the impact of Black scientists in cancer research and immunology….
